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Over the past decades, the number of managed honeybee colonies in the United 
States has been declining. One hypothesis proposed to explain the decline is that 
exposure to xenobiotics might affect bee health without killing the bees directly. The gut 
is important to bee health because it functions as the first physical barrier after honeybees 
ingest xenobiotics. My research investigated the proliferation rate of intestinal stem cells 
(ISCs) as a biomarker of honeybee health after bees were exposed to 12 relevant 
xenobiotics. The study sought to determine whether the xenobiotics showed sub-lethal 
effects on ISC proliferation. I hypothesized that xenobiotics affect ISC proliferation at 
concentrations that do not significantly affect mortality. I studied acute and latent effects 
of selected xenobiotics and one combination of xenobiotics on honeybee lifespan and ISC 
proliferation. Except for a few xenobiotics, I found that most xenobiotics did not show 
ISC proliferation effects. Specifically, a high but sub-lethal concentration of 
hydroxytetracycline decreases proliferation, while tau-fluvalinate only decreases ISC 
proliferation at lethal doses. On the other hand, low concentrations of methoxyfenozide 
increased proliferation without any mortality effects. Thus, I identified several xenobiotic 
that have an effect on ISC proliferation. My results demonstrate sub-lethal effects of 
xenobiotics in a novel, health-relevant context but suggest that ISC proliferation is not a 
general honeybee health indicator. My study does not support a central role of the gut 
physiology in the recent health declines but cannot rule out specific effects that contribute 
to the general decline in honeybee health.
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CHAPTER I 
 
INTRODUCTION 
 
 
Importance of Honeybees 
The European honeybees, Apis mellifera (L.), are very important to the 
agricultural economy. Honeybees are important because they produce honey but more 
significantly, they serve as major insect pollinators. Worldwide, the value of honey in 
2006 was estimated to be about 1.25 billion U.S. dollars  and the value of insect 
pollination about 198 billion U.S. dollars, representing approximately 9.5% of the total 
value of agricultural production (Gallai, Salles et al. 2009). Particularly in North 
America, the economic value of honeybees to agriculture is an estimated 18.6 billion U.S. 
dollars, representing about 11% of the total North American agricultural economy 
(Gallai, Salles et al. 2009). Specifically in North Carolina, honeybee pollinators are 
essential for crops such as blueberries, apples, cucumbers, alfalfa, cotton, and peanuts. 
Averaged between the years of 2000-2004, honeybee pollination resulted in 
approximately $88 million in annual fruit and vegetable production and approximately 
$154 million in total annual crop productivity (N.C. Cooperative Extention 2005). 
Although honeybees are not the only animal pollinators, they are the most important 
species. As generalized feeders, they are useful in a variety of farms. For some crops such 
as almond, apples and blueberries they make up more than 90% of the animal pollinators 
aiding in pollination (Morse and Calderone 2000)
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Honeybee Decline 
Despite their importance, over the past decades, the number of managed honeybee 
colonies in the United States (U.S.) has been declining, regardless of efforts to replenish  
lost colonies using measures such as colony splitting and imports (Ellis, Evans et al. 
2010). From 1947-2008 the number of managed honey producing colonies has dropped 
from 5.9 million to 2.3 million (vanEngelsdorp and Meixner 2010). In 2006, increased 
colony losses were reported and associated with new symptoms: bee colonies left with 
few or no adult bees and no dead bodies. In addition, capped brood and food stores 
usually remained undisturbed by other bees or bee pests. This phenomenon was termed 
colony collapse disorder (CCD) (Ellis, Evans et al. 2010). Between 2008 and 2009, CCD 
attributed honeybee losses decreased, although overall bee population decline increased 
during the same time (vanEngelsdrop, Hayes et al. 2010).  Regardless of whether CCD is 
a real phenomenon or not, European and U.S. honeybee populations are rapidly declining 
and more research is needed to study potential causes.  
Potential Causes of Honeybee Decline  
 
A specific cause for the increased honeybee losses has not yet been identified but 
several hypotheses have been suggested. The proposed causes include known pathogens, 
such as Israeli acute paralytic virus and Nosema ceranae, new pathogens or more virulent 
forms of known pathogens that may not yet have been identified, poor nutrition, poor 
commercial bee management practices, agrochemicals and api-chemicals, or an 
interaction between two or more of the above proposed causes (Ellis, Evans et al. 2010; 
vanEngelsdrop, Hayes et al. 2010). Other threats linked to honeybee decline include the 
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introduction of invasive species such as the Africanized honeybees and intensive land use 
causing loss of habitats. (Berenbaum, Bernhardt et al. 2007). 
Some important honeybee pests are hive mites such as tracheal mites (Acarapis 
woodi Rennie), which infect the trachea (Bradbear 2009), and Varroa mites. These latter 
mites are native to the eastern honeybee, Apis cerana, which are naturally resistant to 
them (Bradbear 2009). However, since the introduction of Varroa mites to the European 
honeybee, in the U.S., the rate of decline per year of honeybee colonies has risen from 
0.06% ± 0.5 to 1.5% ± 0.7 (Ellis, Evans et al. 2010). A wide range of additional 
pathogens such as fungus, bacteria, and viruses can infect honeybees. Fungal pathogens 
include the recently reclassified Nosema apis, a microsporidian that infects epithelial 
cells of the midgut of adult honeybees, and Ascosphaera apis, which competes with the 
bee larvae for food and then ultimately consumes the larvae in a disease called Chalk 
Brood. Bacterial pathogens include Paenibacillus larvae ssp. larvae and Melissococcus 
plutonius which cause American Foulbrood and European Foulbrood, respectively 
(Sanford 1987). Lastly, honeybees are infected by numerous viruses, most of which are 
from the family Dicistroviridae and include the deformed wing virus, black queen virus 
(Knowles 2007) and Israeli acute paralytic virus, which has been linked to CCD through 
a correlation study (Cox-Foster, Conlan et al. 2007). 
Like pests and pathogens, poor nutrition has been linked to reduced honeybee 
fitness. Honeybees are generalist feeders and thus feed on many different pollen types. 
Monoculture farm pollination forces them sometimes to feed on only one kind of pollen 
(Alaux, Ducloz et al. 2010). However, feeding on polyfloral pollen increases the baseline 
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immuno-competence of bees compared with monofloral diets (Alaux, Ducloz et al. 
2010). In addition, honeybees fed different quality pollen, high quality (royal jelly), mid 
quality (pollen), and low quality ( pollen mixed with cellulose) showed an increase in 
intestinal stem cell (ISC) proliferation as food quality decreased (Willard, Hayes et al. 
2011). The proliferation effect of nutrition is presumably due to increased digestive stress 
caused by poor quality diets (Ward, Coleman et al. 2008; Willard, Hayes et al. 2011).   
Xenobiotics 
 
Focusing on one group of the above-mentioned potential causes, my research will 
examine the possible effect of xenobiotics on honeybee health. Xenobiotics are chemicals 
such as drugs, pesticides and carcinogens not normally found in organisms. Their 
presence in honeybees might therefore lead to physiological effects, which in turn might 
cause a decline in honeybee health. For honeybees, substances that could act as health-
deteriorating xenobiotics include insecticides used to control arthropod pest and 
antimicrobials used to alleviate honeybee diseases. While most of these xenobiotics 
might not cause lethal harm to honeybees, there might be sub-lethal effects not yet 
known, which might reduce honeybee health and thus life expectancy. 
 Some insecticides are highly lethal and /or cause behavioral, cognitive, fecundity 
and, developmental sub-lethal effects to honeybees (Decourtye, Lacassie et al. 2003; 
Desneux, Decourtye et al. 2007; Johnson, Ellis et al. 2010; Gregorc and Ellis 2011). For 
example, some insecticides, such as imidacloprid, tau-fluvalinate, coumaphos, and 
chlorothalonil, cause increased midgut epithelial cell death during larvae development 
(Gregorc and Ellis 2011). However, the highly relevant midgut of adult honeybees has 
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not yet been studied. Specifically, nothing is known about the effect of xenobiotics on the 
epithelial and stem cells of the intestine discussed below. 
 Ingested antimicrobials might also cause a disruption of the natural microbial 
flora of the bee guts. Because some microorganisms are beneficial to honeybee food 
digestion, disturbing the microbiota might cause a reduced ability of honeybees to 
properly digest food and thus increase stress to the midgut epithelial cells (Gilliam 1997; 
Rada, Máchová et al. 1997; Kacaniova, Chlebo et al. 2004). Not only might such a 
disturbance decrease epithelial cell viability by increasing digestive demand, but 
disturbing the balanced microflora might also increase pathogen virulence (Gilliam 
1997). Thus, the effect of antimicrobials on honeybee midgut cells needs to be studied.  
There are many different classes of insecticides and this study focuses on 
insecticides from five classes to account for this variety. The insecticides included in the 
study, the classes they are associated with, and their relevance to honeybee health is 
explained next. 
 Coumaphos is an organophosphate used in bee hives to control Varroa mites and 
hive beetles, Aethina tumida. The commercial product Checkmite+™ contains 10% 
coumaphos embedded in a plastic strip (U.S. Enviromental Protection Agency 2003). 
Coumaphos kills mites by inactivating acetylcholinesterase and thus interfering with 
nerve signaling by causing hyperexcitation (Johnson, Ellis et al. 2010). Coumaphos has 
an ld50 of 20.3µg per bee (Johnson, Pollock et al. 2009). Additionally, it has the potential 
to accumulate in the hive at median concentration levels of 1240ppb and high levels of 
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91900ppb in hive wax and 13.1ppb median levels and 5828ppb high levels in pollen 
stores (Mullin, Frazier et al. 2010). 
 Tau-fluvalinate (Apistan™) is a pyrethroid used as a miticide by beekeepers to 
combat Varroa mites. Tau-fluvalinate is highly toxic to honeybees with an acute contact 
LD50 (the dose at which 50 percent of the bees die during a given period) of 0.2 µg/bee 
(U.S. Enviromental Protection Agency 2006). For this reason, the EPA recommends that 
this insecticide not be used in the hives while bees are present. However, in honeybee 
hives, pollen samples contained 40.2ppb median and 2670ppb high concentration levels. 
In wax samples, a median of 3595ppb and a high of 204000ppb were found (Mullin, 
Frazier et al. 2010). 
The accumulation of these two insecticides in beeswax makes their co-occurrence 
in hives likely (Johnson, Ellis et al. 2010; Mullin, Frazier et al. 2010). The co-occurrence 
of these two pesticides in the hives might have synergistic effects on bee health, even at 
sub-lethal concentrations. Such synergistic effects have been found when coumaphos-
treated larval bees were first pretreated with tau-fluvalinate or vice versa, increasing 
honeybee mortality (Johnson, Pollock et al. 2009). Coumaphos might not be toxic alone 
but competition with tau-fluvalinate for the detoxification enzyme cytochrome P450 
might be the cause of the synergistic interaction (Johnson, Ellis et al. 2010). 
Coincidently, honeybees compared with other insects have fewer genes encoding for 
detoxification enzymes in general (Claudianos, Ranson et al. 2006).    
Imidacloprid is a neonicotinoid, a class of insecticides that act as acetylcholine 
receptor agonists. They cause hyperexcitation and eventual death of affected organisms 
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by consistently activating nicotinic cholinergic receptors (Johnson, Ellis et al. 2010). The 
acute oral LD50 for honeybees has been recorded at 30ng/bee (Decourtye, Lacassie et al. 
2003). In honeybee hives, median concentration levels of 20.5ppb and high levels of 
206ppb of Imidacloprid in honeybee pollen and a median concentration  of 8ppb and a 
high of 13.6ppb in wax were detected (Mullin, Frazier et al. 2010). Neonicotinoids have 
been associated with adverse neurological effects and cause abnormal foraging behavior 
even at sub-lethal levels (Decourtye, Lacassie et al. 2003; Yang, Chuang et al. 2008). 
Although the three above-mentioned pesticides are classified as neurotoxins and are 
therefore unlikely to target the gut, they are clearly relevant to honeybee health and my 
tests in this study might expose unspecific or systemic effects.   
Methoxyfenozide is an insect growth regulator and an agonist of the molting 
hormone 20- hydroxyecdysone (20-HE). Although structurally different from 20-HE, 
methoxyfenozide has the same mode of action and thus can cause precocious molting and 
death of susceptible insect larvae (Thacker 2002). Intrepid 2F
®
 and 80 WSP
®
 are brand 
name products containing methoxyfenozide. They are registered for use to control insect 
pests of pome fruit and cotton. The contact LD50 for honeybees is 100µg/bee, which is 
considered relatively non-toxic (California Department Of Pesticide Regulation 2003). In 
honeybee hives, a median concentration of 42.3ppb and a high of 495ppb were found in 
wax samples and a median concentration of 22.3ppb and a high of 128.0ppb were found 
in pollen samples (Mullin, Frazier et al. 2010). 20-HE was tested as a xenobiotic and can 
serve as a positive control for methoxyfenozide. In larvae of many insects, ecdysone, 
specifically its active form, 20-HE, regulates cell proliferation and differentiation 
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(Smagghe, Vanhassel et al. 2005). Ecdysone is present in low amounts in some foraging 
honeybees, and can activate a cascade of gene expression in the brain (Velarde, Robinson 
et al. 2009). If ecdysone receptors exist in the adult honeybee ISCs, exogenic ecdysone or 
ecdysone agonists like methoxyfenozide could have a proliferative effect on these cells.    
Cry1ac, cry1acmod, and cry22 are all toxins produced by the gram-positive soil-
dwelling bacterium Bacillus thuringiensis (Bt). To make transgenic crops, the genes 
coding for these toxins are incorporated into the genome of the respective crops through 
genetic engineering. If successful, the crops express these genes and exhibit the 
insecticidal activity of the toxins. The difference between cry toxin subtypes is their 
species-specific insecticidal activity. The insecticidal specificity of cry toxins is due to 
the need for an interaction with specific receptors located on the host midgut epithelial 
apical microvilli cell surface (Saberon and Bravo 2008). 
 Cry toxins are ingested as protoxins by arthropods and are activated by the 
organism’s midgut proteases. Activated toxins then bind to the cadherin receptor on the 
microvilli membrane causing a conformational change. Additionally, cleaving a 
fragment, helix α-1, from the amino-terminal region exposes hydrophobic regions needed 
to form an oligomer. This oligomer allows the toxin to bind to aminopeptidase, which 
subsequently facilitates the insertion of the toxin into the epithelial cell membrane. This 
forms pores in the membrane causing the cells to leak out their contents (Saberon and 
Bravo 2008).  
 The insecticidal action of cry1ac is targeted at lepidopteran insects. The 
difference between cry1ac and cry1acmod is a modification that allows cry1acmod to 
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form the oligermeric structures necessary for pore formation without a need for cadherin 
receptor binding (Saberon and Bravo 2008). Presently, studies have produced no 
evidence for harm to honeybees caused by the use of Bt crops in the United States 
(Johnson, Ellis et al. 2010) but sub-lethal effects cannot be ruled out and cry1ac is 
commonly used. On the other hand, cry22 was isolated because of its action on 
Hymenoptera (Crickmore 2007), especially ants. Although cry1ac is more prevalent than 
cry22 (Saberon and Bravo 2008), cry22 is more likely to affect honeybees, specifically 
the intestinal epithelium.  
The other xenobiotics tested are antimicrobials, specifically fungicides and 
antibiotics. The purpose for testing this group of xenobiotics is to assess non-specific, 
side effects on the intestinal epithelium, which may be due to changes of the honeybee 
gut microflora with effects on the gut physiology. The few microorganisms that make up 
the gut microflora of honeybees are important, as they seem to have co-evolved with 
pollinating bees in general (Martinson, Danforth et al. 2011).  
Two fungicides, chlorothalonil, and fumagillin will be studied. Chlorothalonil is 
used in agriculture mainly as a fungicide. However, it also has bactericidal, algaecidal, 
microbiocidal and insecticidal activity (Extension Toxicology Network 1994). Its 
mechanism of action is not known, but it is considered relatively non-toxic to honeybees 
(vanEngelsdorp, Evans et al. 2009). The LD50 is >40µg per bee (Food and agriculture 
organization of the United Nations 2006). Additionally, vanEngelsdorp et al. (2009) 
described a new phenomenon of chlorothalonil-contaminated pollen entombed by 
honeybees. In other words, pollen is encapsulated with wax by the bees. While feeding of 
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entombed pollen did not lead to increased mortality, this fungicide might have unknown 
physiological effects on the bees causing the entombing behavior.  
Fumagillin, the second fungicide, is used to combat the previously described 
honeybee pathogen Nosema. It changes the honeybee gut microflora by increasing yeast 
populations (Rada, Máchová et al. 1997), potentially affecting honeybee digestion, and 
health. Fumagillin is not very stable in heat and light and thus does not persist in hives 
(Assil and Sporns 1991). 
Lastly, the broad-spectrum antibiotic hydroxytetracycline (U.S. Enviromental 
Protection Agency 1988) is used to cure honeybee colonies afflicted with American 
foulbrood and European foulbrood. This antibiotic could also potentially harm the normal 
flora of microorganisms in the honeybee gut (Kacaniova, Chlebo et al. 2004) and thus 
affect the honeybee’s ability to digest food. Stressed bees harbor more yeast and yeast-
like organisms in the midgut (Rada, Máchová et al. 1997). Disturbing the natural 
microbial flora of the honeybee midgut might decrease epithelial cell viability by 
increasing digestive demand (Ward, Coleman et al. 2008), and perhaps pathogenic stress 
(Gilliam 1997) and thus increase the rate of epithelial cell death and ISC proliferation 
(Amcheslavsky, Jiang et al. 2009; Buchon, Broderick et al. 2009). 
The Insect Alimentary Canal   
 
The alimentary canal, or digestive tract, is the first point of contact between the 
xenobiotics and the individual bee after ingestion. The alimentary canal of insects is 
divided into the foregut, midgut, and hindgut. The foregut includes the pharynx and 
esophagus, which assist with food ingestion and transportation, and the crop, which can 
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store food before it is transported to the midgut (Snodgrass 1956). The midgut starts 
directly after the proventriculus and ends directly before the start of the Malpighian 
tubules and the ileum. Food digestion and absorption in the honeybee takes place in the 
midgut. Due to this role, the midgut epithelium also acts as the first barrier to ingested 
xenobiotics.  
The midgut epithelium is primarily made up of absorptive columnar cells with 
apical microvilli and secretory goblet cells (Smagghe and Tirry 2001). These epithelial 
cells undergo constant turnover as new cells replace damaged or infected cells (Ohlstein 
and Spradling 2006). Lining the lumen of the midgut is a chitin-protein matrix, the 
peritrophic membrane. This membrane prevents direct contact between ingested food and 
the midgut cells minimizing mechanical but not chemical damage. The waste products 
after digestion move on to the hindgut were water, salts, amino acids, and sugars are 
reabsorbed before excretion of the remainder through the rectum (Smagghe and Tirry 
2001; Hakim, Baldwin et al. 2010).  
Intestinal Stem Cell Proliferation  
 
Ward et al (2008) confirmed the presence of a population of replicative cells in 
the adult honeybee midgut near the basal lamina, originally suggested by Snodgrass 
(1956). These replicative cells have also been identified in adult Tenebrio molitor (Nardi, 
Bee et al. 2010) and adult Drosophila melanogaster (Micchelli and Perrimon 2006). 
These ISCs are round in shape with very little cytoplasm but a large spherical nucleus 
(Raes, Verbeke et al. 1994). The mitotically active ISCs are found in regenerative crypts 
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with only one actively proliferating cell. This cell is usually located closest to the 
basement membrane (Smagghe and Tirry 2001; Ohlstein and Spradling 2006).  
In order to maintain homeostasis, ISC proliferation and differentiation are 
regulated by the ISC niche through many interacting signaling pathways. Some identified 
signaling pathways include JNK, Jak-Stat, p38, EGFR, Hippo, and Notch (Liu, Singh et 
al. 2010; Ren, Wang et al. 2010; Biteau and Jasper 2011). The proliferative activity of 
ISCs is also influenced by environmental factors. Midgut epithelial stem cell nuclei of 
Spodoptera littoralis have ecdysteroid receptors and thus proliferation and differentiation 
is increased when ecdysteroid titers are increased (Smagghe, Vanhassel et al. 2005). In 
addition, feeding of cry toxins from Bt strains AA 1–9 correlated with an increase in stem 
cell differentiation of Heliothis virescens larvae midgut cells (Loeb, Martin et al. 2001). 
When epithelial cells are damaged or stressed in adult Drosophila, EGRF ligands are 
released which in turn leads to increased ISC proliferation and differentiation (Jiang, 
Grenley et al. 2011). Furthermore, feeding-tissue damaging chemicals, such as dextran 
sulfate sodium and bleomycin, increased ISC proliferation and differentiation in 
Drosophila (Amcheslavsky, Jiang et al. 2009). In adult honeybees, ISC proliferation 
increases as digestive demand is increased (Ward, Coleman et al. 2008; Willard, Hayes et 
al. 2011). This increase in proliferation is presumably due to an increase in epithelial cell 
death. ISC proliferation activity is responsive to environmental conditions and thus it 
may be useful as a sub-lethal indicator of honeybee health when bees are exposed to 
xenobiotics. 
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CHAPTER II 
HYPOTHESIS AND SPECIFIC AIMS OF STUDY 
 
 
Hypothesis  
 
I hypothesized that xenobiotics damage epithelial cells and thus cause an increase 
in ISC proliferation at lethal and sub-lethal concentrations based on previous results in 
larvae (Jiang, Grenley et al. 2011). Alternatively, a decrease in proliferation might have 
been predicted. Increased requirements for replication could lead to an exhaustion of ISC 
replicative capacity. Thus, while there might be an immediate increase in ISC 
proliferation, there could be an eventual decrease in the number of replicating cells. In 
addition, ISC poisoning could occur, potentially leading to ISC death or cell cycle arrest. 
This would result in a more immediate decrease in the number of ISCs proliferating (Yan 
and Wajapeyee 2010). To summarize, there are six possible effects of xenobiotics on ISC 
proliferation activity. Proliferation rate could increase, decrease, or be unaffected by the 
treatment at two different time points: directly after treatment or in the long-term (Figure 
1) 
Specific Aims 
Aim 1. My first aim was to test 12 relevant xenobiotics at relatively high 
concentrations for mortality and ISC proliferation effects in honeybee workers.  
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Aim 2. Based on the initial screening experiments, my second aim was to test 
xenobiotics that affected ISC proliferation at high concentrations for their effects on 
honeybee lifespan and ISC proliferation at sub-lethal concentrations.  
Aim 3. My third aim was to test the combination of tau-fluvalinate and 
coumaphos for their possible synergistic effects on honeybee lifespan and ISC 
proliferation at sub-lethal concentration.
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CHAPTER III 
MATERIALS AND METHODS 
 
 
In order to meet the aims of the study, three sets of experiments were performed. 
First, a short- term experiment screened 12 relevant xenobiotics, which were fed or 
exposed to the bees for 7 days, for their effects on honeybee mortality and ISC 
proliferation rate at high concentrations comparable to concentrations bees would 
encounter in hives or during foraging (Table 1). In addition, I used colchicine as a 
positive control for a reduction of cellular proliferation. Colchicine acts to arrest cell 
division by inhibiting spindle fiber formation (Borisy and Taylor 1967). Thus, treatment 
with colchicine was predicted to decrease ISC proliferation significantly. In addition, 
negative vehicle controls were conducted. The results from the first set of experiments 
was used to develop the list of chemicals tested in the second set of longer-term 
experiments. For the long-term study, xenobiotics showing an effect on ISC proliferation 
rate at high concentration were fed to the bees at three sub-lethal concentrations for 7 
days and bees were monitored for up to 22 days. In addition, coumaphos and tau-
fluvalinate (Apistan™) were administered in combination and the bees were again 
monitored for up to 22 days. These two experiments examined in detail the effect of the 
tested xenobiotics on lifespan and ISC proliferation rate. The methodology of my study
was based on previous studies (Ward, Coleman et al. 2008; Willard, Hayes et al. 2011) 
and my own preliminary research.
 
16 
 
Honeybees 
 All honeybees used in the experiments were newly emerged (< 24 hours old 
adults) worker bees (Apis mellifera L.). Before emergence, brood combs were collected at 
random from A. mellifera colonies of mixed descent. Brood combs were kept for no more 
than two days in an incubator. The incubator was set for 24 hours of darkness, 35
o
C, and 
a relative humidity at 60-70%. Newly emerged bees were counted and randomly assigned 
to an experimental treatment. Treatment groups were kept in separate Plexiglas
®
 feeding 
cages (10cm x 7.5cm x 10cm) in the incubator. During the feeding experiments, the 
cohorts were fed queen candy (9:3:1, powdered sugar: water: honey). Throughout the 
experimental period, dead bees were removed from the cage, counted, and recorded. 
Mortality between treatment groups was compared with Kaplan-Meier log-rank tests, 
accounting for any censored data. 
Aim 1- Effect of High Concentration of Xenobiotics on Honeybee Lifespan and ISC 
Proliferation Rate 
 
Preliminary experiments were performed during the summer of 2010 to establish 
protocols for sub-lethal treatments and to screen for mortality and ISC proliferation 
effects of high concentrations of the 12 relevant xenobiotics (Table 1). The relative 
humidity and temperature of the incubator during the feeding period were set for this 
experiment at 35% RH and 25
o
C. Each experimental group consisted of four replicates 
each with 25 individual bees per cage. 
The tested concentrations of the xenobiotics were determined by the highest 
concentration found in hives for hydroxytetracycline, imidacloprid, coumaphos, 
chlorothalonil, and methoxyfenozide (Thompson, Waite et al. 2005; Mullin, Frazier et al. 
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2010). In the case of the Cry protoxins, the highest concentration reportedly found in 
genetically engineered cotton was used (Han, Niu et al. 2010). 20-HE concentration was 
taken from highest concentration found to have an effect on Plodia interpunctella larval 
midgut cells (Rharrabe, Bouayad et al. 2009). For the antimicrobial fumagillin, no hive 
accumulation data were available and consequently the highest recommended use dosage 
as printed on the product label was fed to the bees. These xenobiotics and their vehicles 
controls were mixed with queen candy and provided ad-libitum to the caged bees 
(concentrations specified in Table 1). Tau-fluvalinate was purchased as pre-soaked strips 
(Apistan™) and half strips were placed in the bee cage. All xenobiotics were purchased 
from commercial suppliers (Table 1), except for the Cry protoxins, which were a gift 
from our collaborators (Table 1).  
Aim 2 - Effect of Sub-Lethal Concentrations of Xenobiotics on Honeybee Lifespan and 
ISC Proliferation 
 
The xenobiotics for the second set of experiments were chosen for their 
significant effects on ISC proliferation in the first set of experiments. Methoxyfenozide, 
hydroxytetracycline, and tau-fluvalinate were tested using sub-lethal concentrations 
(Table 2). Because bees are not typically exposed to tau-fluvalinate orally, I exposed the 
bees to Apistan™ strips as in aim 1, but drastically shortened the exposure time (Table 
2).  
For each of these treatment groups, I adhered to the feeding regime used in the 
first experiment. However, to allow easy asses to the food for changing daily, cut 
centrifuge tubes were used instead of feeding plates. In addition, a larger number of bees 
were used to determine long-term honeybee life expectancy. Since sample bees were 
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needed immediately after xenobiotic feeding was stopped to assess acute proliferation 
effects and then again at an older age to assess long-term proliferation effects, the number 
of bees per treatment was increased to two replicate cages of 120-155 bees per treatment. 
For a few treatments (fluvalinate, fluvalinate with coumaphos and hydroxytetracycline), 
insufficient brood was available from UNCG colonies and therefore brood from a local 
beekeeper, and the Wake Forest apiary was used. To facilitate the practical 
implementation of this large-scale experiment, no more than 6 cages were initiated per 
day in a pseudo-randomized design over a period of 20-30 days for a given treatment. 
The cohorts were monitored twice per day for mortality and any dead bees were 
immediately removed. A subset of ten bees from each cage  were sampled at random 
after day seven for quantification of the replication rate of the intestinal stem cells (see 
below). After the seventh day of feeding, surviving bees were fed untreated queen candy 
for up to 22 days. A second sample was taken when the bees were between ages 19-22 
days old or when mortality of the experimental cohort had reached ≥90% before that.  
Aim 3- Effect of Combined Coumaphos and Tau-Fluvalinate  
 In addition to using pesticides singularly to assess treatment effects, one 
combination was tested for synergism. Pesticides described in the literature to have 
synergistic effects on midgut cells are coumaphos and tau-fluvalinate (Johnson, Pollock 
et al. 2009; Johnson, Ellis et al. 2010). This pair was used in combination to assess 
possible synergistic effects on ISC proliferation rate. The same experimental protocol 
described in Aim 2 was used. In the first set of experiments, coumaphos did not show any 
significant effect on ISC proliferation, although mortality effects were observed. Thus, to 
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minimize mortality, coumaphos concentration was reduced 10-fold for all treatment 
groups. The only variation between treatment groups were the tau-fluvalinate exposure 
times (Table 2). As described above, samples of ten workers per cage to measure ISC 
proliferation were taken at 7 days and 21 days of age. 
Proliferation Assays 
 
Following established methods (Ward, Coleman et al. 2008; Willard, Hayes et al. 
2011), stem cell replication was measured by labeling and quantifying replicating cells 
using an immuno-histochemical staining of 5-bromo-2-deoxyuridine (BrdU) (Invitrogen, 
B23151) in intestinal cross-sections. BrdU is a thymidine analogue that does not occur 
naturally, but it is readily incorporated into newly synthesized DNA. Consequently, it is a 
reliable indicator for DNA synthesis, usually indicating cell replication (Ward, Coleman 
et al. 2008). At the time of ISC proliferation assessment, focal bees were fed a 5 mg/ml 
BrdU in 25% queen candy ad libitum for a 24-hour period. Subsequently, bees were 
anaesthetized by chilling and their midguts were dissected. The midguts were fixed in 
Carnoy’s fixative (Table 3) for 24 hours and embedded in Paraplast™ (Fisher, 23-021-
399) wax for sectioning (10µm) using a microtome. These sections of tissue were placed 
in warm water baths on Superfrost Fisher plus™ microscope slides (Fisher, 22-034-979). 
To allow the tissue to adhere to the slides, the water was allowed to evaporate on slide 
warmers (40
o
C) for 24 hours. 
The prepared slides were de-paraffinized in xylene (Fisher, X3P-1GAL), 
rehydrated in graded alcohols (2x 100%, 90%, then 70%), and permeabilized in 
phosphate-buffered saline with triton X-100 (PBST, Table 3). The DNA was then 
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denatured using 2N hydrochloric acid (Fisher, SA56-1). After three washes in PBST, 
unspecific cell antigens were blocked with normal goat serum (Thermo scientific, PI-
31873) and the sections were subsequently incubated with a primary anti-BrdU antibody 
(Phoenix Flow Systems, PRB1U) for 24 hours at 4
o
C. After the 24 hour incubation and 
several washings (3x PBST and 2x PBS, Table 3), the tissue was incubated at roo 
temperature with a peroxidase-conjugated secondary antibody (Jackson Immuno 
Research, 115-035-003) that binds to the BrdU-bound primary antibody. The peroxidase 
cleaved added diaminobenzidine (Sigma, D4418) in a colorimetric reaction. Thus, any 
cell that contained DNA synthesized after ingestion of BrdU, was stained brown. The 
slides were then counterstained blue for approximately five minutes using gill 
hematoxylin (Fisherbrand, CS400-1D) followed by bluing solution (Table 3) for 
approximately one minute. The tissue cross-sections were then dehydrated for five 
minutes each in graded alcohols (50%, 70%, 95%, and 2x 100%) and three times in 
Citrisolv (Fisher, 22-143-975). 
 Labeled cell counts represent a direct measure of the replication rate of the 
intestinal stem cells (Ward, Coleman et al. 2008). Labeled cells were blindly counted in 
one cross-section of the intestine of each individual to estimate overall replication rates 
(Figure 2). Because the number of cells per tissue could differ amongst tissue sections, I 
also standardized ISC proliferation counts relative to the number of labeled cells per 
crypt.  
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Analysis 
Survival analyses were performed with Kaplan-Meier tests, comparing each 
treatment group to its respective control group. In one instance, (15min tau-fluvalinate 
exposure combined with 500ppb coumaphos feeding), no appropriate acetone control 
group was available and a water-fed control group was used instead. If survival was 
comparable or higher than the control, the treatment was considered sub-lethal. For 
experiment two, three survival analyses were performed. Acute mortality was assessed 
during the first 7 days. Latent mortality effects were assessed by comparing survival of 
treatment and control groups between 7 days and the end of the experiment (19-22 days). 
Overall mortality was also assessed for the entire experimental period.  
ISC proliferation was analyzed using a ANOVA. Individuals from treatment 
groups were compared with individuals from control groups matched by emerging date. 
When no exactly matched control group existed, a control group of the closest emerging 
date was chosen. Replicate cage differences were assessed and if no difference was 
found, cages were combined. In addition, analyses were done to evaluate age effects. For 
each treatment group and various water control groups ISC proliferation was compared 
between the 7-day-old workers and workers collected at the end of the experiment (19-22 
days old). 
Lastly, a correlational analysis was performed between mean mortality age and 
the mean number of ISC proliferation cells per crypt for the screening experiments. For 
the sub-lethal experiments, correlational analysis was performed for the mean survival 
age and the mean number of proliferating cells per crypt. 
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CHAPTER IV 
RESULTS 
 
 
Aim 1: Screening Xenobiotics - Mortality  
All vehicle control groups exhibited mortality rates that were not significantly 
different from the water controls (Table 4). Isopropanol had the highest bee mortality 
amongst the vehicle controls (5%). During the 7-day feeding period, more than 50% of 
the bees fed colchicine, coumaphos, hydroxytetracycline, imidacloprid, and fumagillin 
died. Tau-fluvalinate-treated bees showed more than 50% mortality by day 3 (Figure 3). 
Compared with their controls, all xenobiotics except for 20-HE and methoxyfenozide 
showed a significant increase in mortality (Table 4).  
Aim 1: Screening Xenobiotics - ISC Proliferation Rate  
 
 There were a total of 12 xenobiotics and 5 controls tested. No vehicle control 
showed a significant difference in mean cell counts compared with water controls (Table 
5). Labeled cell counts per cross-section ranged from 49 to 461cells. The group means 
ranged from 62 to 323 cells (Table 6). Compared with their controls, colchicine, 
hydroxytetracycline, and tau-fluvalinate showed a significant decrease in ISC 
proliferation based on the preliminary count of the total number of cells per cross section. 
Only methoxyfenozide caused a significant increase in ISC proliferation (Table 6). 
However, when the number of cells per crypt was used as the basis for comparison, the 
effect of methoxyfenozide on proliferation rate was no longer significant, (p= 0.114).  
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Aim 2: Sub-lethal Xenobiotic Concentrations – Mortality 
 
Hydroxytetracycline 
In the short-term, hydroxytetracycline did not cause any significant differences in 
mortality at any concentration (Table 7). Therefore, all concentrations tested were 
considered sub-lethal (Figure 4). Honeybees fed the low and the high concentration of 
hydroxytetracycline showed a latent survival mean higher than the control bees (Table 8). 
In addition, there were no significant difference between controls and the experimental 
group for the medium concentration fed. Therefore, latent mortality was sub-lethal for all 
concentrations fed (Figure 5). Cumulative mean survival over the entire observation 
period was significantly higher than the respective control for honeybees emerging on 
7/11/11 and fed the low concentration of hydroxytetracycline. All other feeding groups 
did not show a significant difference between treatment and controls. Thus, overall all 
hydroxytetracycline treatments were sub-lethal (Figure 6). 
Methoxyfenozide 
 In the short-term, there was no significant difference in mean age of survival 
when bees fed 40ppb methoxyfenozide were compared to controls. However, bees fed 
400 or 2000ppb methoxyfenozide responded with a higher mean survival age (Table 7). 
All three concentrations of methoxyfenozide were sub-lethal during the treatment period 
(Figure 7). There was an increase in latent mean survival age for bees emerging on July 
11 that were given 40ppb methoxyfenozide (Table 8). On the other hand, there was no 
significant difference in latent mortality for all other feeding groups (Table 8). 
Consequently, latent mortality for all the experimental groups was considered sub-lethal 
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(Figure 8). With an increase in mean cumulative survival for bees fed 400ppb, 2000 ppb 
and  40ppb emerging on 7/11/11 but no significant difference in mean survival for bees 
emerging on 7/12/11 who were also fed 40ppb of methoxyfenozide, all methoxyfenozide 
treatments were considered to be sub-lethal overall (Figure 9).   
Tau-fluvalinate 
 Honeybees randomly exposed to three times one minutes of tau-fluvalinate per 
day did not show a significant difference in acute mean survival times when compared to 
controls (Table 7). Thus, this exposure was considered sub-lethal (Figure 10). However, 
bees emerging on 7/11/11 and exposed to three sequential minutes of tau-fluvalinate per 
day responded with a significantly decreased mean survival time when compared to 
controls (Table 7). With exposure times of 15 sequential minutes, bees emerging from 
brood combs acquired from the Wake Forest honeybee lab apiary showed a significantly 
decreased acute mean survival time (Table 7). On the other hand, honeybees emerging 
from brood combs acquired from a nearby North Carolina beekeeper showed an increase 
in acute mean survival time when exposed to 15 sequential minutes of tau-fluvalinate per 
day (Table 7). Tau-fluvalinate exposure did not lead to increased latent mortality except 
for bees emerging on 6/20 that were exposed to tau-fluvalinate for 15 minutes (Figure 
10). These bees had a significantly decreased mean survival age (Table 8). Cumulative 
mortality over the entire observation period was sub-lethal for all concentrations 
examined (Figure 11), except for bees emerging on 6/20/11 which originated from Wake 
Forest and were exposed to 15 minutes of tau-fluvalinate (Table 8).   
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Tau-fluvalinate with Coumaphos 
In the short term, when tau-fluvalinate exposure was combined with 500ppb 
coumaphos, only the lowest exposure time was sub-lethal (Figure 13).The combination of 
tau-fluvalinate with coumaphos significantly increased mortality at all concentrations 
compared to tau-fluvalinate alone (Figure 14). Latent mortality was comparable to 
control bees except for bees from 6/20/11, which responded with a decreased mean 
survival (Table 8). Thus, all group except the feeding group from 6/20/11 showed sub-
lethal effects after treatment (Figure 15). Lastly, cumulative mortality over the whole 
observation period was not significantly increased for any group, except for bees 
emerging on 6/20/11 exposed to 15 minutes of fluvalinate and bees emerging on 7/11/11 
exposed for 3 minutes sequentially (Figure 16).           
Sub-lethal Xenobiotic Concentrations: ISC Proliferation Rate 
Hydroxytetracycline 
In the short-term, hydroxytetracycline ingestion did not cause proliferative 
effects. However, hydroxytetracycline showed a negative latent effect on ISC 
proliferation, dependent on concentration. Only the highest concentration caused a 
significant decrease in ISC proliferation at older ages (Table 10). This effect was not 
observed in bees obtained from Wake forest, which emerged on 6/20/11 (Table 10). 
Comparison of acute and latent proliferation effects showed that later proliferation was 
lower for the two highest concentrations despite water controls not showing this effect 
(Figure 17).  
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Methoxyfenozide 
The lowest concentration of methoxyfenozide fed caused a significant increase in 
proliferation in the short term, although this effect was only significant when the two 
performed experiments were pooled (Table 11). There was no significant effect on 
proliferation in the long term. The highest and the lowest treatment groups showed a 
significant decrease in proliferation from the younger to the older ages (Figure 18). The 
400ppb treatment group showed the same trend but not significantly so. There were no 
concentration effects in the short-term or the long-term.  
Tau-fluvalinate 
There was no significant difference in proliferation when the three exposure times 
of tau-fluvalinate were compared to no exposure bees (Table 11). There were no 
significant differences between younger and older test bees for any exposure time (Table 
11,). No bees were left at the end of day 19 for bees exposed to tau-fluvalinate for 3 
minutes randomly, preventing a study of ISC proliferation at older ages in that group. 
Analyzing for concentration effect of tau-fluvalinate showed that there was no effect of 
increasing exposure on short term or long- term proliferation (Figure 19). 
Tau-fluvalinate with Coumaphos 
There were no acute or latent effects on ISC proliferation of tau-fluvalinate 
combined with coumaphos (Table 13). There were no significant differences between the 
two time points for any exposure time (Table 13). Because there were no bees left at the 
end of day 19 for bees exposed to tau-fluvalinate and coumaphos for 3 minutes randomly, 
latent verses acute comparisons could not be done. With the combination of tau-
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fluvalinate and coumaphos, analyzing for concentration effects showed no effect of 
increasing exposure on short term or long- term proliferation (Figure 20). Analyzing the 
effect of adding coumaphos to tau-fluvalinate showed no significant effect of the 
addition, except in bees that were exposed for 15 minutes to tau-fluvalinate showed a 
significant increase in proliferation (Figure 21). Between the two treatments, older bees 
did not show a significant difference in proliferation between the two treatment groups 
(Figure 21). 
Correlation analysis of mortality means with proliferation mean differences 
showed that there is a negative correlation of mortality and proliferation (Figure 22). 
However, in the second year, this negative relationship was not significant in the short-
term or long-term dataset (Figure 23). 
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CHAPTER V 
 
DISCUSSION 
 
 
Honeybee health is compromised and toxins are likely to play some role in the 
ongoing decline of honeybees. My study exposed adult worker bees to 12 xenobiotics and 
one xenobiotic combination and determined bee survival and ISC proliferation. The 
initial screening suggested a negative impact on honeybee survival for almost all 
xenobiotics but ISC proliferation effects for only three. The follow-up studies of these 
three xenobiotics used a slightly modified experimental paradigm, which affected 
honeybee survival in control and treatment groups. Thus, the two sets of experiments are 
not directly comparable. However, treatment effects in each year could be assessed 
relative to the relevant control groups. In sum, my results suggest sub-lethal effects of 
hydroxytetracycline and methoxyfenozide on ISCs, a positive correlation of survival and 
ISC proliferation, and a decline of ISC proliferation with age.  
The results of aim one of this study showed the effects of high concentrations of 
several xenobiotics on survival and ISC proliferation. Among the 12 xenobiotics screened 
only 20-HE did not have an effect on mortality or proliferation. The absence of a 
proliferation effect was unexpected because 20-HE is the main proliferative hormone 
found in honeybees and it stimulates cell proliferation during larval stages (Smagghe, 
Vanhassel et al. 2005). The results of my study could be due to the receptors being 
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different in the adult honeybee or the wrong concentration been feed to the honeybees 
(Siaussat, Porcheron et al. 2009). I was expecting to see no mortality effect because adult 
honeybees do not need to molt and thus won’t be affected by a premature molt as larval 
insects are (Thacker 2002). 
Several of the xenobiotics decreased survival without causing a change in ISC 
proliferation. These included the two fungicides chlorothalonil and fumagillin. These 
results were not expected because chlorothalonil fed to larval honeybees increased 
cellular apoptosis in the midgut (Gregorc and Ellis 2011). Thus, I expected that midgut 
cells of the adult honeybee would also respond to chlorothalonil with increased cell 
death, leading to an increase in ISC proliferation to replace the dead cells. The difference 
of my results from Gregorc and Ellis result (2011) could stem from the differences in 
concentration used. While I used 1000ppb, which was slightly higher than the highest 
concentration found in honey (Mullin and Frazier et al. 2010), Gregorc and Ellis (2011) 
used 400ppm. Another potential explanation is a difference in larval and adult gut 
physiology (Mansour 1927). In any case, my results suggest that chlorothalonil does not 
affect adult ISC proliferation, even at concentrations that decrease survival. 
The other fungicide used was fumagillin. Fumagillin has been found to change the 
natural microflora of the midgut by causing an increase in yeast cell populations (Rada, 
Máchová et al. 1997). Given the specificity of the possibly co-evolved microbiota of 
corbiculate bees, I expected that changes in the microflora would have caused an increase 
in digestive demand, causing a change in cellular proliferation (Ward, Coleman et al. 
2008; Martinson, Danforth et al. 2011; Willard, Hayes et al. 2011).  Fumagillin reduced 
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bee survival significantly in my experiment and detrimental changes in the gut are likely, 
although I did not confirm effects on the gut microflora. Regardless, ISC proliferation 
was not significantly affected in the surviving bees. The same mortality and ISC 
proliferation results were obtained for the miticide coumaphos, which was also observed 
by Gregorc and Ellis (2011) to cause an increase in honeybee larval midgut cell death. 
The difference between the studies may be explained by a difference between juvenile 
and adult gut physiology, similarly to the difference for chlorothalonil. However, in both 
cases the missing effect of the xenobiotic could also be due to demographic selection, 
meaning that the bees that were least affected were the bees that survived and were 
studied for ISC proliferation. 
Another xenobiotic that did not affect ISC proliferation but decreased survival 
was imidacloprid, the only neonicotinoid tested. While this class of pesticide has been 
shown to cause adverse neurological effects, it is considered a systemic insecticide 
(Decourtye, Lacassie et al. 2003; Yang, Chuang et al. 2008; Johnson, Ellis et al. 2010) 
and unspecific effects on the ISCs might have been possible. However, no effects were 
identified.  
Likewise, none of the three cry toxins caused an effect on proliferation, although 
all lowered bee survival. The absence of proliferation effects was expected for cry1ac and 
cry1ac-mod because these cry toxins affect specifically Lepidopteran hosts. Their 
specificity is due to their dependence on an appropriate host pH, needed for toxin 
activation and host-specific receptors needed for pore formation and thus ion leakage and 
subsequent cell lysis (Bravo, Gill et al. 2007). On the other hand, cry22 has been found to 
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be active in ants, which are also found in the order Hymenoptera, like honeybees. Thus, I 
expected that cry22 would cause increased midgut cell death and result in an increase in 
cell proliferation (de Maagd, Bravo et al. 2003). However, this was not the case. My 
results complement Porcar and Gomez et al (2008) who found that the Bt strain PS86Q3 
which was also active in ants and sawflies did not affect honeybees. Thus, honeybees 
seem to be different from other Hymenoptera and relatively robust against cry toxins. 
However, all cry toxins affect mortality, which must be due to other effects that need to 
be further studied.  
Three xenobiotics decreased both survival and proliferation. These xenobiotics 
were colchicine, the negative control, along with tau-fluvalinate and hydroxytetracycline. 
However, because of the decrease in survival the fed or exposed dose was not considered 
sub-lethal. Colchicine was expected to completely halt cell proliferation (Borisy and 
Taylor 1967). However, as in the case of hydroxyurea proliferation was not completely 
stopped (Ward, Coleman et al. 2008). Thus, it seems colchicine is not able to complete 
stop spindle fiber formation in all the ISCs. Perhaps, it can be detoxified, it might not 
reach the ISCs, or the concentration used was too low. However, the severe reduction of 
survival argues that it did physiologically affect the bees, just like hydroxyurea (Ward, 
Coleman et al 2008). This finding strengthens the case for the existence of important 
proliferative cells in other tissues of the adult honeybees. The decrease of ISC 
proliferation by hydroxytetracycline and fluvalinate was accompanied by a significant 
increase in mortality. Therefore, these two substances were subject to more detailed 
studies at lower concentrations, which are discussed below.  
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 Methoxyfenozide did not affect survival and was the only xenobiotic to increase 
the rate of ISC proliferation compared with its acetone control. However, this effect was 
only significant when the absolute number of labeled cells was counted, not relative to 
crypt number. A positive effect was expected, based on the similarity of methoxyfenozide 
to 20-HE, which has a general proliferative effect (Thacker 2002). In contrast to 20-HE, 
methoxyfenozide probably did not degrade in my experiment or was dosed correctly to 
elicit a proliferation increase. Thus, methoxyfenozide was also subsequently tested at 
different concentrations in order to determine sub-lethal concentration effects. The results 
from this study are also discussed below. 
 Overall, there was an increase in mortality from the first set of experiments to the 
second set. The increase in mortality could be due to the changes made in the 
experimental protocol from the first summer to the second summer. These changes 
included an increase in honeybee density per cage, changes made in the feeding methods, 
relative humidity, and temperature of the incubator. These differences make it difficult to 
compare the results from the first set of experiments to those from the second set. 
However, similar results were obtained by comparisons within these experiments, which 
were valid because treatments were always compared to controls. Overall, the detailed 
studies of tau-fluvalinate, methoxyfenozide, and hydroxytetracycline in the second year 
confirmed the previous results but some differences were observed and more detailed 
observations could be made.  
In the short-term (7 day feeding period), long-term (>12 days after feeding 
period) and, cumulatively (combined observations time), all tested doses of 
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hydroxytetracycline were sub-lethal when compared to their vehicle controls. The highest 
sub-lethal concentration (0.006%) showed a negative proliferative effect compared with 
the control group. This effect was only seen in the older bees and thus this effect was not 
an acute effect as was observed in the first experiment. There was also a negative but 
latent proliferative effect when 0.006% hydroxytetracycline was compared to 0.00012% 
hydroxytetracycline the lowest concentration of hydroxytetracycline fed.  
Hydroxytetracycline tests were performed with bees of different origin. Post-hoc 
analysis of bees fed the highest concentration of hydroxytetracycline revealed that the 
proliferative effect observed was not observed in honeybees originating from Wake 
Forest. The control bees from this apiary however, had a lower ISC proliferation rate 
compared to all other control bees. Thus, the threshold for a decrease in proliferation 
caused by further external stressors might not have been observable. The 0.006% 
hydroxytetracycline effect on proliferation seems to be a delayed effect. The negative 
proliferative effect could be due to a loss of the natural microflora of the midgut causing 
an increase in digestive demand and thus an increase in ISC proliferation rate, exhausting 
replicative capacity (Kacaniova, Chlebo et al. 2004; Ward, Coleman et al. 2008; Willard, 
Hayes et al. 2011). Alternatively, the changes in the microflora may have allowed for 
secondary health infections later in life that compromised the ISC proliferation.  
In combination, my results from both years suggest that the effect of 
hydroxytetracycline on proliferation is dose-dependent. The highest but lethal 
concentration fed showed acute proliferation effects, while the highest sub-lethal 
concentration only showed delayed effects, and lower concentrations did not have any 
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effects. The persistent hydroxytetracycline effects may be due to indirect effects on the 
microflora. Alternatively, the decrease in latent proliferation may have been caused by 
direct damage to the ISC, which could not be alleviated in the long term (Yan and 
Wajapeyee 2010).    
 Methoxyfenozide was sub-lethal at all concentrations and time points. 
Comparing each concentration of the xenobiotic with its control showed that 
methoxyfenozide at the lowest concentration increased acute proliferation. This result 
corroborated my finding in the first year. Furthermore, the highest and the lowest 
concentration fed showed a significant decrease in latent mean proliferation when 
compared to acute mean proliferation. The effect of methoxyfenozide could be due to its 
hormonal activity (Thacker 2002), upregulating ISC proliferation in young bees. The 
decrease in proliferative activity from bees assayed directly after the feeding to bees 
assayed later could be due to the exhaustion of replicative capacity (Ward, Coleman et al. 
2008). This is in contrast to my results from the hydroxytetracycline treated bees, where 
the latent decrease in proliferation was presumably due to long lasting damage to the 
ISCs.  
Acute mortality for bees exposed to tau-fluvalinate was increased, except for bees 
exposed to three randomized minutes of fluvalinate and bees obtained from a nearby 
beekeeper emerging on 6/22/11 and exposed to 15 minutes for fluvalinate. Latent 
mortality was also higher for this group of bees when it could be measured. Bees exposed 
for 3 days during the first set of experiments, were not kept for more than the feeding 
period and thus old age data was not available. The initial finding of decreased ISC 
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proliferation in fluvalinate-exposed bees could not be confirmed for lower exposures, 
regardless of mortality effects. Because fluvalinate exposure to individual bees could not 
be controlled it is possible that bees which were exposed to fluvalinate enough to cause 
proliferation changes also experienced death before assays were done (demographic 
selection), preventing the detection of a potential effect. In sum, I can conclude that 
fluvalinate, which caused the lowest midgut epithelium cell death in larval bees (Gregorc 
and Ellis 2011), only showed proliferation effects at a lethal concentration in adult bees.    
While coumaphos did not show any proliferation effects by its self in the first set 
of experiments, the combination of fluvalinate with coumaphos showed an additive effect 
on ISC proliferation and survival when compared to fluvalinate alone. The combination 
treatment showed significant effects on acute survival, except for the randomized three-
minute treatment. However, only the honeybees originating from Wake Forest exposed to 
fluvalinate for 15 minutes daily responded with an increase in latent mortality. As was 
the case for fluvalinate alone, the combination of fluvalinate with coumaphos showed no 
proliferative effects relative to its controls. However, comparison of honeybees exposed 
to either fluvalinate alone or fluvalinate combined with coumaphos showed that there was 
a two-fold increase in proliferation when coumaphos feeding was added to fluvalinate 
exposure. The additive effect was probably due to the added concentration of coumaphos 
competing for the same xenobiotic detoxification enzymes needed to detoxify fluvalinate 
(Johnson, Pollock et al. 2009). The mortality results from the combined xenobiotics were 
as expected as the combination of fluvalinate with coumaphos significantly decreased 
survival. Despite the mortality effect, I had to reject my hypothesis that there will be a 
 
36 
 
multiplicative change in cell proliferation with the combination of sub-lethal 
concentrations of fluvalinate and coumaphos. Even if the worker bees used in my 
experiment had higher levels of cell death as suggested by the results of  Gregorc and 
Ellis (2011), ISC proliferation did not increase acutely to replace the dead cells. Thus, 
coumaphos and fluvalinate at sub-lethal concentrations even when exposed together do 
not affect adult ISC proliferation, although their combination puts a particular burden on 
the honeybees’ detoxification systems (Johnson, Pollock et al. 2009).  
The positive relationship between ISC proliferation and survival suggested that 
decreased ISC proliferation is associated with increased mortality. However, because 
treatment with fluvalinate was stopped after three days and hydroxytetracycline had a low 
population survival but a high mean survival age due to increased mortality after BrdU 
feeding the correlation is unclear. In addition, the combination of the two miticides, tau-
fluvalinate, and coumaphos were studied for synergistic effects. After studying these four 
treatment groups, a post hoc correlation analysis was done. The analysis showed that 
there was no correlation between survival and proliferation in the short-term or the long-
term. Thus, it is unclear whether ISC proliferative activity is an indicator of life 
expectancy in honeybees.
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CHAPTER VI 
 
CONCLUSIONS 
 
 
This study examined the impact of xenobiotics on the ISC proliferation of the 
honeybee and possibly the health of honeybees. Different xenobiotics have specific 
effects on ISC proliferation and many have no effects at all. The study supports previous 
findings (Ward, Coleman et al. 2008; Willard, Hayes et al. 2011) that ISC proliferation is 
flexible and varies with environmental conditions. My results could be explained by 
direct effects on the ISCs, rather than affecting the need for proliferation (Willard, Hayes 
et al. 2011). However, at least the effect of hydroxytetracycline may also be caused by 
interactions with the gut microfauna and more research is needed.  I confirmed the effect 
of aging on proliferation (Ward, Coleman et al. 2008), although it seems to depend on the 
availability of an additional stressor. This stressor could be the daily tasks of food 
processing and brood care in an observational hive but in cage studies, it could be the 
ingestion of xenobiotics. In addition, the positive stimulation of ISC proliferation by 
methoxyfenozide could mean that there are ecdysteroid receptors located in the midgut, 
which a future study could investigate.  
Considering the availability of xenobiotics in the environment and accumulation 
in the hive (Mullin, Frazier et al. 2010) and the many detrimental effects these 
xenobiotics could have, decoupling mortality effects from behavioral, physiological, and 
anatomical effects at sub-lethal concentrations seems necessary. Simple toxicological 
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tests of pesticides need to be replaced with a battery of tests that take possible 
interactions, latent, and sub-lethal effects into account if we want to ensure the health of 
honey bees. The midgut is an important target organ and my results do not suggest that it 
can be neglected. Even though few compounds affected the ISC proliferation rate, the 
employed assay is easy, relevant, and quantitative and may allow us to predict the health 
consequences of novel pesticides for honeybees. 
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Table 1. Xenobiotic concentrations used in aim one. 
Xenobiotic Supplier Concentration 
Citation for 
concentrations 
(Author, year) 
Colchicine  Sigma-Aldrich 0.5% (Sullivan and Castro 
2005) 
20-hydroxyecdysone MP Chemicals 200ppb (Rharrabe, Bouayad et 
al. 2009) 
DMSO 
a
 Acros Chemical 0.001%  
Acetone
 b
 Mallinckrodt  
chemicals 
0.01%  
Isopropanol
 c
 Fisher 200ppb  
Sodium Bicarbonate 
(SB) 
d
 
Fisher  300ppb  
Cry22 Bt protoxin Nicolas Desneux 300ppb (Han, Niu et al. 2010) 
Cry 1ac Bt protoxin Mario Soberon 
Bruce Tabashnik 
300ppb (Han, Niu et al. 2010) 
Cry1acmod Bt protoxin Mario Soberon 
Bruce Tabashnik 
300ppb (Han, Niu et al. 2010) 
Fumagillin Mann Lake Ltd 0.2% Highest dose allowed 
on Label 
Tau-fluvalinate 
(Apistan™ strips) 
Mann Lake Ltd half a strip   
Hydroxytetracycline Sigma- Aldrich 0.3% (Thompson, Waite et 
al. 2005) 
Imidacloprid Sigma-Aldrich 500ppb (Johnson, Ellis et al. 
2010) 
Coumaphos Sigma-Aldrich 5000ppb (Johnson, Ellis et al. 
2010) 
Chlorothalonil Fluka 1000ppb (Johnson, Ellis et al. 
2010) 
Methoxyfenozide ChemSevice Inc. 400ppb (Johnson, Ellis et al. 
2010) 
a, b, c, d are vehicle controls. They were used as solvents for a = Imidacloprid, b= Methoxyfenozide, 
Coumaphos and Chlorothalonil c = 20-HE and d= Cry1ac, Cry1acmod and Cry22 
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Table 2. Xenobiotic concentration used in aims two and three. 
 
Xenobiotic Supplier 
Concentration or Exposure Time 
 
High Mid Low 
Methoxyfenozide 
ChemSevice 
Inc. 
2000ppb 400ppb 40ppb 
Tau-fluvalinate * 
Mann Lake 
Ltd 
15 minutes 
3 minutes  
sequential 
3 minutes 
randomized 
Hydroxytetracycline 
Sigma- 
Aldrich 
0.006% 0.003% 0.00012% 
Tau-fluvalinate * 
+ 
500ppb Coumaphos 
Mann Lake 
Ltd 
Sigma-
Aldrich 
15 minutes 
3 minutes  
sequential 
3 minutes 
randomized 
* Tau-fluvalinate was exposed to bees using the commercial Apistan™ strip. A full strip was placed in 
each cage for the indicated exposure time per day for 7 days.  
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Table 3. Buffers and solutions used in proliferation assay. 
 
Solutions and Buffers Recipe 
PBS 
Add 8g of NaCl, 0.2g of KCl, 1.44g of Na2HPO4, 
and 0.24g of KH2PO4 to 1 L of water and adjust to 
PH 7.4. 
PBST Add 500µl of triton X-100 to 1000ml of 1 X PBS 
Carnoy’s Fixative 
60% ethanol + 30% chloroform + 10% glacial acetic 
acid 
Hematoxylin Bluing Solution 
Add 1 gram sodium bicarbonate to 1000ml distilled 
water. 
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Table 4. Worker bee mortality during xenobiotic screening. 
 
Treatment Total N N surviving after day 7 Percent 
Survived 
20-HE 100 96 96.00% 
Chlorothalonil
b
 100 95 95.00% 
Coumaphos
a b 
100 23 23.00% 
Cry1AC
a b 
100 87 87.00% 
Cry1ACmod
a b 
100 83 83.00% 
Cry22
a b
 100 92 92.0% 
Tau-fluvalinate
a
 101 23 22.77% 
Fumagillin
a
 101 42 41.58% 
Imidacloprid
a b
 100 47 47.00% 
Hydroxytetracycline
a
 103 7 6.79% 
Methoxyfenozide 100 99 99.00% 
Controls 
Water 100 99 99.00% 
Colchicine
a
 78 5 6.41% 
Acetone 100 100 100.00% 
DMSO (Imidacloprid)
 
25 25 100.00% 
Isopropanol (20-HE)
 
100 95 95.00% 
Sodium bicarbonate 100 100 100.00% 
a. feeding these xenobiotics results in a significant decrease in mortality as compared to the water 
control. b. feeding these xenobiotics results in a significant decrease in mortality as compared to the 
respective vehicle controls. 
 
 
50 
 
Table 5. Mean difference in absolute number of proliferating cells between xenobiotics and respective 
controls. 
Control Mean Treatment Mean  
Mean Difference 
 (Control-
Treatment) ± SE 
ANOVA 
Water 261.7. 
Colchicine* 169.3  92.4 ± 30.7 
F(1,11) = 9.1, p 
= 0.012 
Acetone 245.9 15.8 ± 27.7 
F(1,21) =  0.3 , 
p = 0.575 
DMSO 252.9 8.8 ± 22.6 
F(1,17) =  , 0.2 
p = 0.701 
Isopropanol 280.6 -18.9 ± 27.5 
F(1,18) = 0.5 , p 
= 0.501 
Sodium bicarbonate 238.3 -23.5 ± 27.8 
F(1,20) = 0.7 , 
p = 0.408 
Fumagillin 250.1 11.6 ± 23.6 
F(1,19) = 0.2 , 
p = 0.629 
Hydroxytetracycline* 62.3 199.4 ± 29.2 
F(1,11) = 46.6 , 
p < 0.001 
Tau-fluvalinate* 164.3 97.5 ± 29.4 
F(1,16) =  , p = 
0.004 
Cry1ac 269.8 -8.1 ± 33.7 
F(1,18) = 0.1 , 
p = 0.813 
Cry1acmod 248.5 13.3 ± 25.9 
F(1,19) = 0.3 , 
p = 0.615 
Acetone 245.9 
Coumaphos 275.9 -30.0 ± 32.7 
F(1,20) = 0.8 , 
p = 0.371 
Chlorothalonil 275.5 -29.6 ± 35.4 
F(1,22) = 0.7 , 
p = 0.411 
Methoxyfenozide* 323.1 -77.2 ± 30.3 
F(1,21) = 6.5 , 
p = 0.019 
DMSO 252.9 Imidacloprid 263.0 -10.1 ± 39.9 
F(1,18) = 0.8 , 
p = 0.386 
Isopropanol 280.6 20-HE 254.1 26.5 ± 28.2 
F(1,20) = 0.9 , 
p = 0.359 
Sodium 
bicarbonate 
238.3 
Cry22 290.7 -52.5 ± 31.3 F(1,21) = 2.8 , 
p = 0.108 
*Xenobiotics showing a significant mean difference from control.
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Table 6. Mean difference of the relative number of proliferating cells per crypt between xenobiotics and 
respective controls. 
Control Mean Treatment Mean  
Mean Difference 
 (Control-
Treatment) ± SE 
ANOVA 
 
Water 
4.9. 
Colchicine* 3.1 
1.8±0.7 F(1,9 ) =7.4  
, p = 0.024 
Acetone 4.7 
0.2±0.5 F(1,18 ) = 0.2 
, p = 0.662 
DMSO 5.4 
-0.5±0.5 F(1,16 ) =0.8  
, p = 0.399 
Isopropanol 4.8 
0.1±0.6 F(1,15 ) =0.0  
, p = 0.849 
Sodium bicarbonate 5.5 
-0.6±0.4 F(1,17 ) =2.0  
, p = 0.177 
Fumagillin 4.6 
0.3±0.5 F(1,17 ) =0.5  
, p = 0.509 
Hydroxytetracycline* 1.8 
3.1±0.4 F(1,13 ) =  , p 
< 0.001 
Tau-fluvalinate* 3.3 
1.6±0.7 F(1,10 ) =6.1  
, p = 0.033 
Cry1ac 4.5 
0.4±0.4 F(1,18 ) =1.1  
, p = 0.316 
Cry1acmod 4.8 
0.02±0.4 F(1,18 ) =0.0  
, p = 0.958 
Acetone 4.7 
Coumaphos 5.3 
-0.6±0.5 F(1,17 ) =1.4  
, p = 0.249  
Chlorothalonil 4.8 
-0.1±0.4 F(1,20 ) 
=0.02  , p = 
0.887  
Methoxyfenozide 5.4 
-0.7±0.5 F(1,20 ) =2.7  
, p = 0.114 
DMSO 5.4 Imidacloprid 5.3 
0.1±0.6 F(1,16 ) 
=0.04  , p = 
0.851 
Isopropanol 4.8 20-HE 4.8 
-0.3±0.7 F(1,18 ) =0.2  
, p = 0.630 
Sodium 
bicarbonate 
5.5 Cry22 5.3 0.2±0.6 F(1,19 ) =0.1  
, p = 0.733 
*Xenobiotics showing a significant mean difference from control. 
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Table 7. Data on mortality during the xenobiotic feeding in the second set of experiments (Acute) 
 
Bee Emerging 
Date  
Conc. Total N N of Deaths Estimated Mean 
 Survival Age 
Kaplan Meier test 
Hydroxytetracycline 
7/11/11 0.00012% 151 54 6.6 ± 0.2 χ2 = 0.0, p = 0.970 
Control 155 60 7.0 ± 0.1 
7/12/11 0.00012% 152 79 6.7 ± 0.1 χ2 = 0.0, p = 0.992 
Control 148 70 6.2 ± 0.2 
8/2/11 & 8/10/11 0.003% 601 313 6.3 ± 0.1 χ2 = 0.7, p= 0.409 
Control 446 248 6.4 ± 0.1 
8/10/11 0.006% 314 185 6.0 ± 0.1 χ2 = 0.0, p = 0.962 
Control 149 85 5.9 ± 0.2 
Methoxyfenozide 
7/11/11 40ppb 153 35 7.3 ± 0.1  χ2 =1.2, p = 0.265 
Control 151 41 6.8 ± 0.2 
7/15/11 40ppb 179 116 5.6 ± 0.2 χ2 =0.2, p = 0.618 
Control 160 100 5.8 ± 0.2 
7/15/11 400ppb 316 171 6.4 ± 0.1* χ2 =7.2, p= 0.007 
Control 160 100 5.8 ± 0.2 
7/15/11 2000ppb 309 155 6.8 ± 0.1* χ2 =16.1, p < 
0.001 Control 160 100 5.8 ± 0.2 
Tau-fluvalinate 
8/2/11 3 min. rand. 295 165 6.5 ± 0.1 χ2 =0.2, p= 0.631 
Control 297 163 6.7 ± 0.1 
7/11/11 3 min. seq. 147 73 6.4 ± 0.1
a 
χ2 =6.9, p= 0.009 
Control 155 60 7.0 ± 0.1 
7/12/11 3 min seq. 156 94 5.9 ± 0.1
a 
χ2 =5.2, p= 0.023 
Control 148 70 6.2 ± 0.2 
6/20/11 15 min seq. 150 91 6.0 ± 0.2
a 
χ2 =20.4, p < 
0.001  Control 150 64 7.1 ± 0.1 
6/22/11 15 min seq. 154 40 7.0 ± 0.2* χ2 =11.6, p= 0.001 
Control 150 67 6.3 ±  0.2 
Tau-fluvalinate with Coumaphos 
8/3/11 3 min. rand. 296 174 6.2 ±  0.1 χ2 = 0.8, p= 0.371 
Control 309 184 6.0 ±  0.1 
7/11/11 3 min. seq. 149 75 6.7 ±  0.1
a 
χ2 =11.1, p= 0.001 
Control 151 41 6.8 ± 0.2  
7/15/11 3 min seq. 149 127 4.4 ± 0.1 
a 
χ2 = 45.3, p < 0.001 
Control 160 100 5.8 ± 0.2   
6/21/11 15 min seq. 300 154 6.1 ± 0.1 
a 
χ2 =10.9, p= 0.001 
Control 150 64 7.1 ± 0.1  
*Estimated mean survival is significantly higher than control. aEstimated mean survival is significantly 
lower than control (treatment not considered sub-lethal). 
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Table 8 : Mortality data for the period after xenobiotics were fed (Latent) in the second experimental set 
 
Date Bees 
Emerged 
Conc. Total N 
N of 
Deaths 
Estimated 
Mean 
Survival Age 
Kaplan Meier test 
Hydroxytetracycline 
7/11/11 
0.00012% 87 58 15.4 ± 0.6 * 
χ2 = 5.5, p= 0.019 
Control 85 75 14.3 ± 0.7 
7/12/11 
0.00012% 63 33 19.9 ± 0.4* 
χ2 = 23.0, p < 0.001 
Control 68 54 16.1 ± 0.7 
8/2/11 
0.003% 141 111 14.3 ± 0.3 
χ2 = 0.8, p= 0.386 
Control 114 93 14.7 ± 0.3 
8/10/11 
0.003% 107 85 11.6 ± 0.3 
χ2 = 3.4, p= 0.065 
Control 54 41 12.4 ± 0.5 
8/10/11 
0.006% 109 69 13.8 ± 0.3* 
χ2 = 8.5, p= 0.004 
Control 54 41 12.4 ± 0.5 
Methoxyfenozide 
7/11/11 
40ppb 108 77 13.7 ± 0.6 * 
χ2 = 6.1, p= 0.013 
Control 100 86 12.8 ± 0.5 
7/15/11 
40ppb 53 38 13.8 ± 0.8 
χ2 = 0.4, p= 0.538 
Control 50 37 15.9 ± 0.6 
7/15/11 
400ppb 125 89 14.3 ± 0.5 
χ2 = 0.0, p= 0.936 
Control 50 37 15.9 ± 0.6 
7/15/11 
2000ppb 55 35 15.4 ± 0.7 
χ2 = 2.5, p= 0.117 
Control 50 37 15.9 ± 0.6 
Tau-fluvalinate 
8/3/11 
3 min. rand. 110 90 14.3 ± 0.3 
χ2 = 2.5, p= 0.117 
Control 114 93 14.7 ± 0.3 
7/11/11 
3 min seq. 63 39 16.4 ± 0.8* 
χ2 = 7.5, p= 0.006 
Control 85 75 14.3 ± 0.7 
7/15/11 
3 min seq. 52 40 15.6 ± 0.9 
χ2 = 0.0, p= 0.902 
Control 68 54 16.1 ± 0.7 
6/20/11 
15 min seq. 43 39 15.7 ± 0.8*a 
χ2 = 48.3, p < 0.001 
Control 85 22 18.9 ± 0.4 
6/22/11 
15 min seq. 104 53 15.1 ± 0.5* 
χ2 = 6.2, p= 0.013 
Control 54 35 12.9 ± 0.6 
Tau-fluvalinate with Coumaphos 
8/3/11 
3 min. rand. 102 80 13.9 ± 0.4* 
χ2 = 11.1, p= 0.001 
Control 105 62 15.2 ± 0.5 
7/11/11 
3 min seq. 64 34 17.9 ± 0.6* 
χ2 = 36.0, p < 0.001 
Control 100 86 12.8 ± 0.5 
7/15/11 
3 min seq. 12 2 15.5 ± 5.5 
χ2 = 1.3, p= 0.251 
Control 50 37 15.9 ± 0.6 
6/20/11 
15 min. seq. 40 16 17.5 ± 1*a 
χ2 = 4.9, p= 0.026 
Control 85 22 18.9 ± 0.4 
6/22/11 
15 min seq. 66 15 19.6 ± 0.6* 
χ2 = 32.8, p < 0.001 
Control 54 35 12.9 ± 0.6 
*Estimated mean survival is significantly different from control. aEstimated mean survival is not sub-
lethal when compared to control. 
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Table 9: Overall mortality of workers in the second experimental set 
 
Date Bees Emerged Conc. Total N N of Deaths 
Estimated Mean 
Survival 
Kaplan Meier test 
Hydroxytetracycline 
7/11/11 0.00012% 151 112 11.2 ± 0.6 χ2 = 2.5, p= 0.114 
Control 155 135 10.7 ± 0.6 
7/12/11 0.00012% 152 112 12.0 ± 0.6* χ2 = 8.1, p= 0.004 
Control 148 124 10.3 ± 0.6 
8/2/11 0.003% 326 275 9.5 ± 0.3 χ2 = 0.1, p= 0.755 
Control 297 256 9.4 ± 0.3 
8/10/11 0.003% 275 233 7.6 ± 0.3 χ2 = 0.2, p= 0.685 
Control 149 126 7.6 ± 0.4 
8/10/11 0.006% 314 254 8.1 ± 0.3 χ2 = 2.3, p= 0.113 
Control 149 126 7.6 ± 0.4 
Methoxyfenozide 
7/11/11 40ppb 153 112 11.6 ± 0.6* χ2 = 6.9, p= 0.009 
Control 151 127 10.3 ± 0.5 
7/15/11 40ppb 179 154 7.4 ± 0.4 χ2 = 0.5, p= 0.460 
Control 160 137 8.4 ± 0.5 
7/15/11 400ppb 316 260 9.0 ± 0.3* χ2 = 4.8, p= 0.029 
Control 160 137 8.4 ± 0.5 
7/15/11 2000ppb 309 247 9.6 ± 0.3* χ2 = 13.0, p < 0.001 
Control 160 137 8.4 ± 0.5 
Tau-fluvalinate 
8/2/11 3 min. rand. 295 255 8.998 χ2 = 1.7, p= 0.191 
Control 297 256 9.4 ± 0.3 
7/11/11 3 min. seq. 147 112 10.3 ± 0.6 χ2 = 0.1, p= 0.747 
Control 155 135 10.7 ± 0.6 
7/12/11 3 min seq. 156 134 8.6 ± 0.5 χ2 = 3.2, p= 0.072 
Control 148 124 10.3 ± 0.6 
6/20/11 15 min. seq. 144 130 8.4 ± 0.5* χ2 = 70.0, p < 0.001 
Control 159 86 13.4 ± 0.6 
6/22/11 15 min. seq. 154 93 12.2 ± 0.6* χ2 = 25.4, p < 0.001 
Control 131 102 8.3 ± 0.5 
Tau-fluvalinate with Coumaphos 
8/2/11 3 min. rand. 296 254 8.4 ± 0.3 χ2 = 1.5, p= 0.223 
Control 309 246 8.6 ± 0.4 
7/11/11 3 min. seq. 149 109 11.2 ± 0.6 χ2 = 3.0, p= 0.085 
Control 151 127 10.3 ± 0.5 
7/12/11 3 min seq. 149 129 5.1 ± 0.4*a χ2 = 40.3, p < 0.001 
Control 160 137 8.4 ± 0.5 
6/20/11 15 min. seq. 148 114 8.2 ± 0.5*a χ2 = 47.1, p < 0.001 
Control 159 86 13.4 ± 0.6 
6/22/11 15 min. seq. 132 71 12.9 ± 0.7 χ2 = 19.8, p < 0.001 
Control 131 102 8.3 ± 0.5 
*Estimated mean survival is significantly different from control. aEstimated mean survival is not sub-lethal 
when compared to control. 
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Table 10: Effect of hydroxytetracycline feeding on intestinal stem cell proliferation rate 
(cells/crypt) 
 
 Sampled 
Time 
Concentration 
(N) 
 Mean  Control 
Mean 
 Water 
Control 
(N) 
Mean 
Difference 
± SE 
 ANOVA  
Acute 0.00012% 
(11) 
4.138 4.1   (10) 0.08 ± 0.5 F = 0.0, p 
= 0.984 
0.003% 
(8) 
4.35 3.52 (9) -0.84 ± 0.4 F = 4.4, p 
= 0.540 
0.006% 
(7) 
3.620 3.142 (15) -0.48 ± 0.4 F = 1.2, p 
= 0.286 
Latent  0.00012% 
(10) 
3.43 3.318 (5) -0.11 ± 0.6 F = 0.0, p 
= 0.843 
0.003% 
(8) 
3.715 3.028 (5) 0.69 ± 0.5 F = 2.3, p 
= 0.161 
0.006% 
(7)  
2.169 2.802 (15) 0.63 ± 0.6 F = 1.3, p 
= 0.273 
0.006% 
a
  
(4) 
2.636 2.345 (10) -0.2 ± 0.8 F = 0.1, p 
=0.710 
0.006% 
b 
(3) 
1.545 3.715 (5) 2.17 ± 0.4* F = 28.97, 
p = 0.002 
Comparison of mean acute proliferation and mean latent proliferation 
Concentration 
Acute 
proliferation 
Sample (N) 
Mean 
Latent 
proliferation 
Sample  (N) 
Mean 
Mean 
Difference 
± SE 
ANOVA 
0.00012% 11 4.138 10 3.432 0.71 ± 0.4 
F = 2.7, p 
= 0.117 
0.003% 8 4.355 8 3.028 
1.33 ± 0.4 
* 
F = 11.3, 
p = 0.005 
0.006% 7 3.620 7 2.169 1.5 ± 0.4 * 
F = 12.6, 
p = 0.004 
0.006% 
a 
4 3.738 4 2.636 1.10 ± 0.6 
F = 3.4, p 
= 0.115 
0.006 
b 
3 3.462 3 1.545 
1.92 ± 0.3 
* 
F = 41.3, 
p = 0.003 
*Significant difference in mean cells per crypt per tissue. Since bees for 0.006% were acquired from 
different sources, they were also analyzed separately. a   Bees originating from Wake Forest apiary. b  
Bees originating from UNCG apiary. 
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Table 11: Effect of methoxyfenozide feeding on intestinal stem cell proliferation rate 
(cells/crypt) 
 
Sampled 
Time 
Concentration 
(ppb) (N) 
Mean Control 
Mean 
Acetone 
control 
(N) 
Mean 
Difference 
± SE 
ANOVA 
Acute 40 7/11/11 (5) 3.843 2.728  (4) -1.12 ± 0.5 F = 5.3, p = 
0.054 
 40 7/15/11 (5) 5.289 4.093  (5) -1.20 ± 0.6 F = 4.1, p = 
0.078 
 Combined 40 
(10) 
4.566 3.487 (9) -1.08 ± 0.5 
* 
F = 4.7, p = 
0.045 
 400 (9) 3.491 4.093 (5) 0.60 ± 0.4 F = 1.8, p = 
0.200 
 2000 (10) 3.887 4.093 (5) 0.21 ± 0.4 F = 0.3, p = 
0.609 
Latent 40 7/11/11 (12) 2.640 2.768  (10) 0.13 ± 0.2 F = 0.7, p = 
0.419 
 400 (11) 3.186 2.768 (10) -0.42 ± 0.3 F = 1.6, p = 
0.220 
 2000 (8) 2.727 2.768 (10) 0.04 ± 0.3 F = 0.0, p = 
0.894 
Comparison of mean acute proliferation and mean latent proliferation 
Concentration Acute 
proliferation 
Sample (N) 
Mean Latent 
proliferation 
Sample  (N) 
Mean Mean 
Difference 
± SE 
ANOV
A  
40 7/11/11 5 3.843 12 2.640 1.20 ± 0.3* F = 
18.9, p 
= 0.001 
40 7/15/11 5 4.093 N/A N/A N/A N/A 
Combined 40 10 4.566 12 2.640 1.93 ± 0.4* F = 
25.4, p 
< 0.001 
400 9 3.491 11 3.186 0.31 ± 0.4 F = 0.5, 
p = 
0.487 
2000 10 3.887 8 2.727 1.16 ± 0.4* F = 8.5, 
p = 
0.010 
Acetone 5 4.093 10 2.768 1.33 ± 0.2* F = 
39.4, p 
< 0.001 
*Significant difference in mean cells per crypt per tissue. 
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Table 12: Effect of tau-fluvalinate exposure on intestinal stem cell proliferation rate 
(cells/crypt) 
 
Sampled 
Time 
Concentration 
(N) 
Mean Control 
Mean 
Water 
Control 
(N) 
Mean 
Difference 
ANOVA 
Acute 3 Randomized
a 
(11) 
3.516 3.753 9 -0.24 ± 0.4 F = 0.3, p = 
0.587 
 3 minutes 
sequential 
(7)  
4.280 3.886 (15) -0.40 ± 0.5  F = 0.6, p = 
0.454 
 15 min (10) 3.005 3.093 Combined 
(11) 
0.09 ± 0.3  F = 0.1, p = 
0.798 
Latent 3 minutes 
sequential 
(10) 
3.077 3.318 (5) 0.24 ± 0.7 F = 0.2, p = 
0.669 
 15 minutes 
(13) 
3.314 3.385 Combined 
(15) 
0.07 ± 0.3 F = 0.5, p = 
0.820 
Comparison of mean acute proliferation and mean latent proliferation 
Concentration Acute 
proliferation 
Sample (N) 
Mean Latent 
proliferation 
Sample  (N) 
Mean Mean 
Difference 
± SE 
ANOVA  
3 minutes seq. 7 4.28 10 3.077 1.20 ± 0.6 F = 4.4, 
p = 
0.052 
15 minutes  10 3.005 13 3.314 -0.31 ± 
0.2 
F = 1.7, 
p = 
0.200 
aLatent proliferation effects could not be assessed because no samples were available.  
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Table 13: Effect of tau-fluvalinate exposure with coumaphos feeding on intestinal stem 
cell proliferation rate (cells/crypt) 
 
Sampled 
Time 
Exposure 
Time 
(N) 
Mean Control 
Mean 
Control 
(N) 
Mean 
Difference 
ANOVA 
Acute 3 
randomized
b 
(8) 
4.391 4.782 0.02% 
Acetone 
(8) 
0.39 ± 0.6 F = 0.4, p = 
0.517 
 3 sequential 
(8) 
3.845 4.782 0.02% 
Acetone 
(8) 
0.93 ± 0.6 F = 2.4, p = 
0.147 
 15 minutes 
(10) 
2.622 2.594 Water
a
  
(6)
 
-0.03 ± 0.4 F = 0.0, p = 
0.941 
Latent 3 sequential 
(11) 
3.535 3.366 0.02% 
Acetone 
(10) 
-0.17 ± 0.4 F = 0.2, p = 
0.701 
 15 minutes 
(10) 
2.986 2.345 Water
a
 
(10) 
-0.64 ± 0.5 F = 1.6, p = 
0.228 
Comparison of mean acute proliferation and mean latent proliferation 
Concentration Acute 
proliferation 
Sample (N) 
Mean Latent 
proliferation 
Sample  (N) 
Mean Mean 
Difference 
± SE 
ANOVA  
Acetone 8 4.782 10 3.366 1.42 ± 
0.6* 
F = 5.3, 
p = 
0.036 
3 minutes seq.  8 3.845 11 3.535 0.31 ± 0.4 F = 0.6, 
p = 
0.445 
15 minutes 10 2.622 10 2.986 -0.36 ± 
0.3 
F = 1.6, 
p = 
0.227 
*Significant difference in mean cells per crypt per tissue. a  Water was used as the control because of the 
bees originating from Wake Forest and  which had no acetone control. bLatent proliferation effects could 
not be assessed because no samples were available.   
 
59 
 
 
 
Figure 1. Possible acute and latent effects of xenobiotics on ISC proliferation. At each age at which proliferation is 
assessed, proliferation could either increase stay the same or decrease relative to control.  
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Figure 2: Cross-section of honeybee midgut. A is 40x magnified, b is 100x magnified and c is 400x 
magnified. Black arrow points to brown stained newly synthesized cell. Red circle surrounds a stem cell 
crypt. For data analysis, only cells found in well-defined cone shaped crypts were counted.  
A 
B 
C 
Lumen 
Lumen 
Lumen 
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Figure 3. Percent of sampled population surviving past treatment period (7 days) (left y-axis indicated as bars) and 
absolute number of proliferating cells per tissue section (right y-axis indicated by squares). Due to high mortality, the 
feeding period for tau-fluvalinate was 3 days. Vehicle controls shown with light blue bars and grey squares. All 
xenobiotics except for 20-HE and methoxyfenozide did not have an effect on survival   
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Figure 4: Acute survival curves of honeybees feed hydroxytetracycline. A) Honeybees 
emerging on 7/11/11/11 fed 0.00012% hydroxytetracycline. B) Honeybees emerging on 
7/12/11 fed 0.00012% hydroxytetracycline. C) Honeybees emerging on 8/2/11 and 8/10/11 
fed 0.003% hydroxytetracycline. D) Honeybees emerging on 8/10/11 fed 0.006% 
hydroxytetracycline. None of the concentrations fed caused a reduction in mortality compared 
to the control bees.  
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Figure 5: Latent survival curves of honeybees after hydroxytetracycline feeding. All concentrations tested 
were sub-lethal.  
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Figure 6: Cumulative survival curves of honeybees over 19-22 days of bees fed hydroxytetracycline. All 
concentrations were sub-lethal when compared to control.  
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Figure 7: Acute survival curves of honeybees fed methoxyfenozide. All three concentrations were sub-
lethal when compared to the acetone control.  
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Figure 8: Latent survival curves of honeybees after methoxyfenozide feeding. All concentrations tested 
were sub-lethal. 
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Figure 9: Cumulative survival curves of honeybees over 19-22 days of bees fed methoxyfenozide. All 
concentrations were sub-lethal when compared to control.  
 
68 
 
C
u
m
u
la
ti
v
e 
S
u
rv
iv
al
  
3 min. rand (8/2/11)   
Survival 
  
  
Xenobiotic 
  Control 
 
 
 
3 min. seq. (7/11/11) 3 min. seq. (7/12/11) 
  
15 min seq. (6/20/11) 15 min seq. (6/22/11) 
 
 
Age 
 
Figure 10: Acute survival curves of honeybees exposed to tau-fluvalinate. Bees exposed to 3 sequential 
minutes of tau-fluvalinate responded with a decrease in survival compared to water controls (p= 0.009 for 
bees emerging on 7/11/11 and p = 0.023 for bees emerging on 7/12/11). Honeybees exposed to 15 minutes 
of tau-fluvalinate originated from either Wake Forest’s apiary or from a local beekeeper differed: Only the 
bees from Wake Forest responded to the treatment with an increase in mortality (p < 0.001).  
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Figure 11: Latent survival curves of honeybees after tau-fluvalinate exposure. All concentrations were 
sub-lethal except for bees from 6/20/11 or bees acquired from Wake Forest University. These bees have a 
significantly decreased mean survival age (p < 0.0001) when treated.  
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Figure 12: Cumulative survival curves of honeybees over 19-22 days of bees exposed to tau-fluvalinate. 
All concentrations were sub-lethal except for bees from 6/20/11 or bees acquired from Wake Forest. These 
bees had a significantly decreased mean survival age when treated (p < 0.0001). 
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Figure 13: Acute survival curves of honeybees exposed to tau-fluvalinate with coumaphos feeding. Only 
the lowest exposure time (3 minutes randomized exposure) did not show significant departures from the 
survival of the respective controls.  
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Figure 14: Comparing tau-fluvalinate only exposure and exposure with fluvalinate and 
coumaphos. The comparison showed that there was a decrease in estimated mean survival for 
all concentrations tested when tau-fluvalinate was combined with coumaphos.  P= 0.015, 
0.000, 0.049 for 15 minutes, 3 minutes sequential and 3 minutes randomized exposure, 
respectively.  
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Figure 15: Latent survival curves of honeybees after tau-fluvalinate exposure with coumaphos feeding. 
All concentrations were sub-lethal except for bees from 6/20/11 or bees acquired from Wake Forest 
University. These bees had a significantly decreased mean survival age when treated (p=0.026). 
 
74 
 
C
u
m
u
la
ti
v
e 
S
u
rv
iv
al
  
3 min. rand. (8/2/11)   
Survival 
Xenobiotic 
  Control 
 
 
 
 
 
3 min. seq. (7/11/11) 3 min. seq. (7/12/11) 
  
15 min. seq. (6/20/11) 15 min. seq. (6/22/11) 
  
Age 
 
Figure 16: Cumulative survival curves of honeybees over 19-22 days of bees exposed to tau-fluvalinate 
with coumaphos feeding. All concentrations were sub-lethal except for bees from 6/20/11 or bees 
acquired from Wake Forest University (p < 0.0001) and bees emerging on 7/12/11 exposed 3 sequential 
minutes of tau-fluvalinate (p < 0.0001).  
 
75 
 
 
 
Figure 17: Effect of hydroxytetracycline ingestion on intestinal stem cell proliferation rate immediately after 
proliferation (Acute) and 19-22 days after proliferation (Latent). There was a significant difference between bees as 
they age for the two highest concentrations fed. p = 0.005 for 0.003% and p = 0.004 for 0.006% hydroxytetracycline. 
The concentration effect on proliferation between 0.006% and 0.003% b p = 0.024.  
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Figure 18: Effect of methoxyfenozide ingestion on intestinal stem cell proliferation immediately after proliferation 
(Acute) and 19-22 days after proliferation (Latent).  There were no dosage effects. The 40ppbb and the 200ppbc caused 
aging effects (p = 0.001 and p = 0.01 respectively).  There was also an age effect between short-term acetone samples 
and long-term acetone samplesa (p= 0.036).  
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Figure 19:  Effect of tau-fluvalinate exposure on intestinal stem cell proliferation immediately after proliferation 
(Acute) and 19-22 days after proliferation (Latent).  There were no dose effects of tau-fluvalinate exposure. However 
there was a trend towards an age effect when bees were exposed to 3 minutes of tau-fluvalinate sequentially (p = 
0.052).  
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Figure 20: Effect of tau-fluvalinate exposure with coumaphos ingestion on intestinal 
stem cell proliferation immediately after proliferation (Acute) and 19-22 days after 
proliferation (Latent). For bees sampled immediately after exposure there was a 
significant decrease in proliferation between the highest exposure time and the control 
acetone (p = 0.001) or the lowest exposure time (p= 0.006). However, it should be noted 
that the bees from the highest exposure experiment originated from Wake Forest and a 
local beekeeper, not from the UNCG apiary. The only age effect seen was within the 
acetone control bees (p = 0.036)  
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Figure 21: Comparison of proliferative effects of adding coumaphos to tau-fluvalinate. A) Bees sampled after day 7 
directly after the xenobiotic exposure, acute proliferation assay. B) Bees sampled at older ages, latent assay. There 
were no bees from 3 minutes of randomized exposure after 19 observation days left. Thus, BrdU assays could not be 
done.  Only bees exposed to 15 minutes of tau-fluvalinate showed a significant increase in proliferation when 
coumaphos feeding was combined with exposure (p < 0.001), with a mean difference to the control of 2.07 labeld 
cells /crypt. Bees assayed after 19 days of obsevation did not show a significant differnce in proliferation between the 
two treatment groups.  
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Figure 22: Mean survival difference of xenobiotic treatments from respective control treatments compared 
to the mean proliferation difference of xenobiotic treatments from respective control. Treatments show a 
negative correlation between relative ISC proliferation and mortality (r= -0.493, p= 0.04).  
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Figure 23: Acute and latent survival correlated to acute and latent intestinal stem cell (ISC) 
proliferation rate mean differences from controls. Survival is not correlated to ISC 
proliferation rate short-term (r= -0.207, p= 0.477) or long-term (r=-0.580, p= 0.061). 
 
 
 
 
 
 
 
 
 
 
 
 
